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 Abstract — Perhaps the most appealing opportunity is represented by gaining 
inspiration from nature for the precise tailoring of biomaterials with finely 
tuned unique functional properties. A very promising model is represented by 
Human Elastin-Like Polypeptides (HELP), repetitive artificial polypeptides based 
on penta- or hexa- peptidic motifs that characterize elastin. These protein 
polymers retain several peculiar biophysical properties as, the reversible inverse 
phase transition, changing the solubility and aggregation state in response to 
temperature variation. The smart nature of this class of compounds makes 
them attractive for many applications in the biomedical and biotechnological 
fields, in particular for biomaterial development. The Trans2Care project aiming 
to translating scientific and technological expertise into products for the 
biomedical field represents an exciting and challenging environment to best 
exploit the potential these biomimetic macromolecules. 
Index Terms — recombinant protein, elastin, biomimetic strategy, advanced 
biomaterials
———————————————————
1 INTRODUCTION
1.1 Elastin, a model for protein-based artificial biopolymers
Bio-mimicry, the concept of taking inspiration from nature is perhaps among the most appealing strategies to create customized biomaterials with finely tuned 
peculiar features. 
Elastomeric proteins, well represented among Vertebrates are among the 
components that received considerable attention. Elastin, one of the components 
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of the extracellular matrix, possesses rubber-like elasticity undergoing deformation 
without rupture and provides an important model for biomaterials design. Another 
peculiar extensively studied characteristic of elastomeric proteins is coacervation. 
Under appropriate conditions of concentration, ionic strength and increasing 
temperature, the protein is known to separate from solution as a second phase. It 
has been shown that this behavior is mainly due to the presence of the hydrophobic 
(VPGXG) pentapeptide, typical of the mammalian protein. 
In 1974, Urry et al. first developed artificial polypeptides mimicking these repeated 
hydrophobic motifs characterizing bovine tropoelastin. [1]. 
In the human protein, the most structurally regular sequence is represented by the 
repetition of the (VAPGVG) hexapeptidic motif. It has been shown that the VAPGVG 
motif is biologically functional. 
By a molecular biology approach, a regularly repeated domain from human tropoelastin 
was chosen as a basic modulus to obtain the Human Elastin-Like Polypeptides 
(HELPs). These artificial proteins can be employed in the production of innovative 
micro- and nano-structured biomaterials with a huge potential for employment in 
the biotechnological and biomedical fields.
1.2 HELP biopolymers family 
In our lab the HELP macromolecule, based on the most structurally regular module of human tropoelastin was developed and expressed in bacteria [2]. The polypeptide is 
soluble in aqueous solution below a critical temperature, whereas it forms aggregates 
above this temperature. This process, known as “inverse” phase transition, is fully 
reversible. 
A second synthetic gene was developed, and a polypeptide, named HELP1, based 
only on the most consistently repeated peptide sequence of human tropoelastin was 
obtained (Figure 1). 
Figure 1. Schematic representation of the two HELP and HELP1 prototypes. 
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Overall, the work carried on in our lab is aimed at the production of a family of artificial 
polypeptides that exhibit different and variable physicochemical properties. The two 
prototype macromolecules HELP and HELP1 that differ in their primary structure 
have been characterized from the physic-chemical point of view, showing a different 
behaviour in relation to the different environmental conditions [3]. Both biopolymers 
are able to give reversible hydrogels under defined conditions by raising temperature 
(30-37°C). 
Relatively large yields have been recently achieved upon optimization of biopolymer 
expression and of the purification steps, in the range of hundreds of milligrams of 
purified product per liter of bacterial culture. [4] 
A key feature of these recombinant products is related to the modular structure 
of the synthetic genes that allows the tailoring of the macromolecule for a specific 
application. 
In this light, the HELPs can be viewed as prototypes whose functionality can 
be implemented by simply fusing peptidic regions to the C-terminal part of the 
biopolymers. The addition of a bioactive domain of choice will result in the conferring 
specific function to the whole product. 
2 BIOTEChNOLOGICAL AND BIOMEDICAL APPLICATIONS
Many recent examples show the potential of these polypeptides for a wide range of biomedical applications, and to build structures with highly controlled 
properties and behaviour [5]. 
The thermoresponsive self-assembly properties of these macromolecules are of 
particular interest to develop functional biomaterials, especially in the field of targeted 
delivery and controlled release of active molecules.
A method for preparation of 3D matrices with hydrogel features has been patented 
recently [6] and prosecution procedures are currently ongoing in Europe and USA 
(Figure 2).
Figure 2.  Stable HELP hydrogel matrix.
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This method represents a valuable option to preserve cell viability and functions 
as it avoids the use of harsh chemical reagents commonly used for preparation of 
matrices [7]. A huge potential for biomaterial development is foreseen. For example, 
one interesting feature is represented by the possibility to encapsulate cells in the gel 
maintaining their viability. 
As shown in Figure 3, cells spheroids can grow within the gel.
Figure 3. Viable cell encapsulation in 3D HELP matrix.
3 AIMS IN TRANS2CARE PROjECT
Proteinaceous material represents a promising alternative to chemically synthesised, traditional biomaterials still commonly employed in the biomedical 
field. HELPs represent promising innovative macromolecules and show high potential 
for a wide range of applications. Thus, we intend to exploit the Trans2Care partners’ 
expertise and knowledge to:
a) exchange ideas between traditionally distinct research areas and bringing together 
the competences to devise the employment of HELP biopolymers for specific demand;
b) provide the HELP compounds to the partners to setup experimental work;
c) develop commercial applications of HELPs and biomaterials derived. 
In particular, collaboration with:
•	 University of Nova Gorica (PP3), on development of innovative environmental 
biosensors;
•	 Treviso Tecnologia (PP5), on supporting technology transfer of existing and future 
HELP products;
•	 ZTM (PP10), on development of advanced cell growth and delivery systems.
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